copes pharmacy limited

2

copes pharmacy limited Company Information

Share COPES PHARMACY LIMITED
Live 
MatureSmallHealthy

Company Number

04475604

Registered Address

c/o croucher needham limited, market house, saffron walden, essex, CB10 1JZ

Industry

Dispensing chemist in specialised stores

 

Telephone

02087642910

Next Accounts Due

March 2025

Group Structure

View All

Directors

Ashok Soni22 Years

Shareholders

ashok soni 100%

copes pharmacy limited Estimated Valuation

£392.4k

Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £392.4k based on a Turnover of £1.5m and 0.27x industry multiple (adjusted for size and gross margin).

copes pharmacy limited Estimated Valuation

£0

Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £0 based on an EBITDA of £-144.8k and a 3.56x industry multiple (adjusted for size and gross margin).

copes pharmacy limited Estimated Valuation

£0

Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £0 based on Net Assets of £-295k and 2.3x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Copes Pharmacy Limited Overview

Copes Pharmacy Limited is a live company located in saffron walden, CB10 1JZ with a Companies House number of 04475604. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2002, it's largest shareholder is ashok soni with a 100% stake. Copes Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.5m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Copes Pharmacy Limited Health Check

Pomanda's financial health check has awarded Copes Pharmacy Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

1 Strong

positive_score

5 Regular

positive_score

6 Weak

size

Size

annual sales of £1.5m, make it smaller than the average company (£12.1m)

£1.5m - Copes Pharmacy Limited

£12.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (5.3%)

9% - Copes Pharmacy Limited

5.3% - Industry AVG

production

Production

with a gross margin of 30.9%, this company has a comparable cost of product (30.9%)

30.9% - Copes Pharmacy Limited

30.9% - Industry AVG

profitability

Profitability

an operating margin of -13.2% make it less profitable than the average company (2.2%)

-13.2% - Copes Pharmacy Limited

2.2% - Industry AVG

employees

Employees

with 20 employees, this is below the industry average (86)

20 - Copes Pharmacy Limited

86 - Industry AVG

paystructure

Pay Structure

on an average salary of £22.7k, the company has an equivalent pay structure (£22.7k)

£22.7k - Copes Pharmacy Limited

£22.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £74k, this is less efficient (£138.2k)

£74k - Copes Pharmacy Limited

£138.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 26 days, this is near the average (31 days)

26 days - Copes Pharmacy Limited

31 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 71 days, this is close to average (68 days)

71 days - Copes Pharmacy Limited

68 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 27 days, this is in line with average (30 days)

27 days - Copes Pharmacy Limited

30 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (16 weeks)

0 weeks - Copes Pharmacy Limited

16 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 163.5%, this is a higher level of debt than the average (59.4%)

163.5% - Copes Pharmacy Limited

59.4% - Industry AVG

COPES PHARMACY LIMITED financials

EXPORTms excel logo

Copes Pharmacy Limited's latest turnover from June 2023 is estimated at £1.5 million and the company has net assets of -£295 thousand. According to their latest financial statements, Copes Pharmacy Limited has 20 employees and maintains cash reserves of £3 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Turnover1,479,9651,352,7181,910,5861,130,393972,077676,371770,517593,114864,514635,010636,397623,337883,332821,019
Other Income Or Grants00000000000000
Cost Of Sales1,023,301912,0851,314,038796,429688,939468,620526,433403,101606,837440,523439,755440,040622,248571,847
Gross Profit456,664440,633596,548333,965283,138207,751244,084190,012257,677194,486196,642183,297261,084249,172
Admin Expenses651,801386,235406,805451,894397,037224,111229,893123,687252,938265,392228,261308,653210,04637,988
Operating Profit-195,13754,398189,743-117,929-113,899-16,36014,19166,3254,739-70,906-31,619-125,35651,038211,184
Interest Payable15,54712,69212,91412,6209,3695,0216,0633,4661,5023,6865,0212,83800
Interest Receivable2,10253311111381571673671921971928153
Pre-Tax Profit-208,58342,240176,840-130,538-123,130-21,2248,29563,2263,429-74,395-36,448-128,11351,043211,188
Tax0-8,026-33,600000-1,576-12,645-686000-13,271-59,132
Profit After Tax-208,58334,214143,240-130,538-123,130-21,2246,71950,5812,743-74,395-36,448-128,11337,772152,055
Dividends Paid00000000000000
Retained Profit-208,58334,214143,240-130,538-123,130-21,2246,71950,5812,743-74,395-36,448-128,11337,772152,055
Employee Costs453,973382,912279,677250,663204,172147,647143,317122,405139,046103,527101,65584,262119,355100,641
Number Of Employees2018141311887866576
EBITDA*-144,846105,314241,083-63,568-76,774-13,08017,47169,60527,798-47,846-8,532-101,59255,619215,765

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Tangible Assets62,14178,15494,792127,657147,740222219,78139,56159,3687332,034
Intangible Assets168,600202,878237,156271,434305,71219,68022,96026,24029,52032,80036,08039,36042,64045,920
Investments & Other0000045450000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets230,741281,032331,948399,091453,45219,72723,00726,24229,52252,58175,64198,72843,37347,954
Stock & work in progress77,70383,25295,39775,94072,54859,59577,45955,86159,79164,78961,47668,02176,64280,224
Trade Debtors109,18299,307328,593142,437131,29067,234102,02559,622113,72769,41879,33584,160129,536121,775
Group Debtors00000000000000
Misc Debtors43,75680,53379,77195,70294,44261,46021,15525,957018,23961,99975,38593,85146,779
Cash3,00481,0604,27017,3504,15132,63930,178103,76143,17433,57845,29731,4488511,208
misc current assets00000000000000
total current assets233,645344,152508,031331,429302,431220,928230,817245,201216,692186,024248,107259,014300,880249,986
total assets464,386625,184839,979730,520755,883240,655253,824271,443246,214238,605323,748357,742344,253297,940
Bank overdraft56,28716,42259,50316,63457,02820,97820,21119,336000000
Bank loan00000000000000
Trade Creditors 199,565198,950211,860219,846169,163153,218132,308134,653185,039162,449155,473136,101154,326145,785
Group/Directors Accounts000000450000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities392,528364,069341,462377,860312,53230,49923,09825,840000000
total current liabilities648,380579,441612,825614,340538,723204,695175,662179,829185,039162,449155,473136,101154,326145,785
loans96,380113,589160,603186,674153,43146,17067,14887,319046,22967,17787,31800
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00169,955169,955169,955000107,46178,95675,73272,50900
provisions14,63318,57817,23423,42927,114000000000
total long term liabilities111,013132,167347,792380,058350,50046,17067,14887,319107,461125,185142,909159,82700
total liabilities759,393711,608960,617994,398889,223250,865242,810267,148292,500287,634298,382295,928154,326145,785
net assets-295,007-86,424-120,638-263,878-133,340-10,21011,0144,295-46,286-49,02925,36661,814189,927152,155
total shareholders funds-295,007-86,424-120,638-263,878-133,340-10,21011,0144,295-46,286-49,02925,36661,814189,927152,155
Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Operating Activities
Operating Profit-195,13754,398189,743-117,929-113,899-16,36014,19166,3254,739-70,906-31,619-125,35651,038211,184
Depreciation16,01316,63817,06220,08313,18000019,77919,78019,80720,4841,3011,301
Amortisation34,27834,27834,27834,27823,9453,2803,2803,2803,2803,2803,2803,2803,2803,280
Tax0-8,026-33,600000-1,576-12,645-686000-13,271-59,132
Stock-5,549-12,14519,4573,39212,953-17,86421,598-3,930-4,9983,313-6,545-8,621-3,58280,224
Debtors-26,902-228,524170,22512,40797,0385,51437,601-28,14826,070-53,677-18,211-63,84254,833168,554
Creditors615-12,910-7,98650,68315,94520,910-2,345-50,38622,5906,97619,372-18,2258,541145,785
Accruals and Deferred Income28,45922,607-36,39865,328282,0337,401-2,74225,840000000
Deferred Taxes & Provisions-3,9451,344-6,195-3,68527,114000000000
Cash flow from operations-87,266348,998-32,77832,959138,32727,581-48,39164,49228,6309,49435,596-47,354-36253,640
Investing Activities
capital expenditure0015,8030-470,895000000-79,1190-52,535
Change in Investments0000-450450000000
cash flow from investments0015,8030-470,8500-450000-79,1190-52,535
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00000-45450000000
Other Short Term Loans 00000000000000
Long term loans-17,209-47,014-26,07133,243107,261-20,978-20,17187,319-46,229-20,948-20,14187,31800
Hire Purchase and Lease Commitments00000000000000
other long term liabilities0-169,95500169,95500-107,46128,5053,2243,22372,50900
share issue0000000000000100
interest-13,445-12,159-12,903-12,609-9,231-4,864-5,896-3,099-1,310-3,489-4,829-2,75753
cash flow from financing-30,654-229,128-38,97420,634267,985-25,887-26,022-23,241-19,034-21,213-21,747157,0705103
cash and cash equivalents
cash-78,05676,790-13,08013,199-28,4882,461-73,58360,5879,596-11,71913,84930,597-3571,208
overdraft39,865-43,08142,869-40,39436,05076787519,336000000
change in cash-117,921119,871-55,94953,593-64,5381,694-74,45841,2519,596-11,71913,84930,597-3571,208

copes pharmacy limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for copes pharmacy limited. Get real-time insights into copes pharmacy limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Copes Pharmacy Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for copes pharmacy limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

copes pharmacy limited Ownership

COPES PHARMACY LIMITED group structure

Copes Pharmacy Limited has 1 subsidiary company.

Ultimate parent company

COPES PHARMACY LIMITED

04475604

1 subsidiary

COPES PHARMACY LIMITED Shareholders

ashok soni 100%

copes pharmacy limited directors

Copes Pharmacy Limited currently has 1 director, Mr Ashok Soni serving since Jul 2002.

officercountryagestartendrole
Mr Ashok Soni63 years Jul 2002- Director

P&L

June 2023

turnover

1.5m

+9%

operating profit

-195.1k

0%

gross margin

30.9%

-5.27%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

-295k

+2.41%

total assets

464.4k

-0.26%

cash

3k

-0.96%

net assets

Total assets minus all liabilities

copes pharmacy limited company details

company number

04475604

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

July 2002

age

22

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

UK

address

c/o croucher needham limited, market house, saffron walden, essex, CB10 1JZ

last accounts submitted

June 2023

copes pharmacy limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to copes pharmacy limited. Currently there are 2 open charges and 0 have been satisfied in the past.

charges

copes pharmacy limited Companies House Filings - See Documents

datedescriptionview/download